BioAmp

BioAmp is a research compound marketed by BioLongevity Labs as a targeted metabolic formula. Each capsule contains 100 mg of ATX-304 (also known as OS-01), described as a pan-AMPK activator. The product is sold strictly for laboratory and investigational/research use only and is not intended for human consumption or medical treatment.

Pharmacology

ATX-304 (OS-01) is a synthetic small molecule designed to activate AMP-activated protein kinase (AMPK) — often called the “metabolic master switch.” AMPK activation mimics some effects of exercise and calorie restriction by:

• Enhancing insulin sensitivity
• Promoting glucose uptake in cells
• Increasing fat oxidation
• Supporting mitochondrial function and biogenesis

This mechanism is similar to compounds like metformin and certain natural AMPK activators (e.g., berberine), but ATX-304 is engineered for potentially higher potency and pan-AMPK effects.

Safety Profile

Human clinical data on ATX-304 / OS-01 is very limited. It is still considered an investigational compound with sparse published safety studies in humans.

Known / Expected Effects (based on AMPK activators in general):

• Potential improvements in metabolic markers (insulin sensitivity, energy production)
• Possible mild gastrointestinal discomfort
• Fatigue or increased energy (individual variation)

Potential Risks:

• Metabolic Shifts: Strong AMPK activation can cause changes in blood glucose, lactate levels, or energy metabolism that may not be suitable for everyone.
• Gastrointestinal Issues: Nausea, diarrhea, or stomach discomfort (common with many AMPK activators).
• Cardiovascular / Mitochondrial Effects: Theoretical risks of altered heart rate, blood pressure, or cellular energy dynamics, especially at higher doses or with long-term use.
• Unknown Long-Term Safety: No extensive long-term human trials are widely available for this specific compound. Effects on liver, kidney, or hormonal systems remain largely uncharacterized in healthy populations.

Contraindications & Cautions

• Individuals with diabetes, hypoglycemia, or those taking blood sugar-lowering medications (risk of excessive glucose lowering).
• People with mitochondrial disorders or certain metabolic conditions.
• Pregnancy, breastfeeding, or individuals under 18.
• Those with pre-existing heart, liver, or kidney conditions.

Drug Interactions: Potential interactions with metformin, other AMPK activators, or medications affecting glucose/insulin.

Product-Related Risks

As a research chemical sold in capsule form:

• Purity and exact dosing may vary between batches.
• Long-term stability and bioavailability data are limited.
• Risk of contaminants or inconsistent manufacturing.

Important Note: This is a neutral, educational overview based on available product information and general knowledge of AMPK activators. BioAmp contains an investigational compound with very limited human safety data. Significant uncertainties exist regarding both short- and long-term risks. This information is not medical advice and does not encourage use. Consult a qualified healthcare professional before considering any research compound. Comply with all local laws and regulations regarding research chemicals.